Yin Pingshan

Professor Zhang Fujun is presented through St. Stamford Modern Cancer Hospital Guangzhou materials as Director of the Belt and Road International Training Co-construction Unit of the Chinese Anti-Cancer Association. His international activity includes delivering a keynote report on iodine-125 radioactive particle implantation at the 7th ASEAN International Integrative Oncology Forum in Jakarta on July 12. In that same forum context, he introduced minimally invasive treatment options for intermediate and advanced cancers.

His described techniques include radioactive seed implantation, microwave ablation, and radiofrequency ablation. The iodine-125 approach is explained as implanting a tiny radioactive source into or around a tumor under CT or other imaging guidance, delivering continuous localized irradiation. The planning steps are also outlined: doctors plan the needle insertion route, particle quantity, and distribution before treatment.

Education

No specific education details are stated in the available materials.

Work experience

• Director, Belt and Road International Training Co-construction Unit — Chinese Anti-Cancer Association (keynote speaker at 7th ASEAN International Integrative Oncology Forum; July 12, Jakarta).

Clinical focus and techniques

Zhang Fujun’s interventional oncology focus centers on precision minimally invasive procedures.

• Iodine-125 radioactive particle implantation (iodine-125 seed implantation) under CT or imaging guidance.
• Radioactive seed implantation.
• Microwave ablation.
• Radiofrequency ablation.

Professional societies and certifications

• Chinese Anti-Cancer Association (CACA) — Belt and Road International Training Co-construction Unit director.

Academic output

No publication metrics are stated in the available materials.

Courses and advanced training

• Keynote report at the 7th ASEAN International Integrative Oncology Forum (July 12, Jakarta, Indonesia).

Awards and recognition

No awards are stated in the available materials.

For patients traveling from abroad, the clinic’s cross-border pathway includes remote appointment steps and coordinated in-person admission for MDT diagnosis and treatment, then follow-up visits after discharge. Zhang Fujun’s featured technology—iodine-125 radioactive particle implantation—targets precision treatment for complex tumors using imaging-guided planning and continuous localized irradiation.